Yamamoto et al. investigated the accuracy of lactoferrin in predicting IBD relapse and proposed a cut-off value of 170 ug/g (sensitivity 76%, specificity 76%), although authors did not find a statistically significant difference between relapsed and nonrelapsed patients [43,49]. This evidence concerns the gene LTF and inflammatory bowel disease.